{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "document", "Document"], "kwargs": {"metadata": {"source": "/home/guanzhideng145/research/ip_portal/patent_kg/patents/721-US20210060002A1(Pending) not sealed.pdf"}, "page_content": "US 2021/0060002 A1\n\nEV711 LAMP ** SANALANNI\n\nEVTICORNA\n\nFig . 1B\n\nFig . 10\n\nMar. 4, 2021 Sheet 2 of 16\n\nUS 2021/0060002 Al\n\nPatent Application Publication\n\nColocalization coaliciont Aa\n\nFig. 1C\n\nPatent Application Publication\n\nUS 2021/0060002 A1\n\nMar. 4 , 2021 Sheet 3 of 16\n\nZIKV - positive RNA\n\nCart\n\nVRBAIZIKV - Envelope proteinyDAPI ZIKV - envelope protein\n\nFig . 10\n\nJEV + RNA probe\n\nFig . 1E\n\n20\n\nGAPDH\n\nFig . 1F\n\nMar. 4, 2021 Sheet 3 of 16\n\nPatent Application Publication\n\nUS 2021/0060002 Al\n\nFig. 1D\n\n\u56db \u5927 RNAibeaPI * * | JEV+RNA\n\nFig. 1E\n\nFig. 1F\n\nZIKV-envelope protein\n\nBAPTA-AM\n\nJE\n\nprobe\n\n|\n\nPatent Application Publication\n\nMar. 4 , 2021 Sheet 4 of 16\n\nUS 2021/0060002 A1\n\nFig . 2A\n\n88\n\ncela OMV Basta\n\nJEV\n\nFig . 2B\n\nMar. 4, 2021 Sheet 4 of 16\n\nPatent Application Publication\n\nUS 2021/0060002 Al\n\nRelatvle infectivity @al Herbamrine) 004\n\nFig. 2B\n\ning!\n\nPatent Application Publication\n\nMar. 4 , 2021 Sheet 5 of 16\n\nUS 2021/0060002 A1\n\n100+\n\nRelatvie\n\nInfectivity ( % )\n\nZIKV\n\n0\n\nlog Derbainel M\n\nFig . 2C\n\nwilot wios WT001\n\nOSING\n\nJEV - NS1 -\n\nGAPDH\n\nFig . 2D\n\nMar. 4, 2021 Sheet 5 of 16\n\nUS 2021/0060002 Al\n\nPatent Application Publication\n\n\u540c & Ey eR RdG.858i 2 Relatvie infectivity (%} g i 2 a 4 logiBerbamine], ahi\n\nFig. 2C\n\n3\n\nPatent Application Publication\n\nUS 2021/0060002 A1\n\nMar. 4 , 2021 Sheet 6 of 16\n\nDMSO 5PM\n\n50NM\n\nZIKV - E\n\nGAI\n\nAPDH\n\nFig . 2E\n\nJEY Her\n\nlogkal .\n\n?\n\n2\n\ntout - post - infection\n\nFig . 27\n\nFig . 2G\n\nMar. 4, 2021 Sheet 6 of 16\n\nUS 2021/0060002 Al\n\nPatent Application Publication\n\nSEY ther dug IClti,fasls B&R A 4 HO \u2018ee tt\n\nFig. 2F\n\nFig. 2G\n\nhove-pest-indeeti an\n\n\u540c\n\nPatent Application Publication\n\nMar. 4 , 2021 Sheet 7 of 16\n\nUS 2021/0060002 A1\n\nBerbamine\n\nFig . 3A\n\nMock\n\nBerbamine\n\nFig . 3B\n\nMar. 4, 2021 Sheet 7 of 16\n\nUS 2021/0060002 Al\n\nPatent Application Publication\n\nBerbamine\n\nSRN ASDAPI\n\nFig. 3A\n\nAIRE DAPI\n\nMock Berbamine omn \u52a0 40 min\n\nFig. 3B\n\nTime after infection\n\nPatent Application Publication\n\nMar. 4 , 2021 Sheet 8 of 16\n\nUS 2021/0060002 A1", "type": "Document"}}